QWM
TNYA icon

Quadcap Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Quadcap Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.39K Hold
10,000
– – ﹤0.01% 430
2026
Q1 		$6.92K Hold
10,000
– – ﹤0.01% 398
2025
Q4 		$7.12K Buy
+10,000
New +$13.6K ﹤0.01% 394

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadcap Wealth Management's TNYA Position: Q2 2026 in Review

Quadcap Wealth Management held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 10,000 shares worth $7.39K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

Quadcap Wealth Management first reported a position in TNYA in Q4 2025 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Quadcap Wealth Management held 10,000 shares of Tenaya Therapeutics worth $7.39K as of Q2 2026.
  • Quadcap Wealth Management left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Quadcap Wealth Management's portfolio in Q2 2026, its #430 holding.
  • Quadcap Wealth Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.